药物线索与渴求同药物使用及复吸的关联:系统综述与荟萃分析
随机效应模型显示所有线索与渴求指标均与药物使用/复吸显著相关(OR 2.05,95%CI 1.94-2.15),线索诱导渴求、真实线索或图片等 moderator 关联更强。结论提示线索与渴求指标在药物使用和复吸中起重要作用,支持在治疗各阶段纳入渴求评估。
要点
- 所有线索与渴求指标均与后续药物使用/复吸显著前瞻性关联,OR 2.05(95%CI 1.94-2.15)。
- 线索诱导渴求、真实线索或图片、药物使用结局、同日时间间隔等 moderator 关联较强。
- 结果支持在治疗各阶段(早至初级保健)纳入渴求评估。
核心结论
- 药物线索与渴求指标在药物使用和复吸结局中起重要作用,是物质使用障碍的重要机制。
- 临床结果支持在治疗各阶段纳入渴求评估,早至初级保健。
研究设计与样本
- 纳入报告时间1线索与渴求指标与时间2药物使用或复吸前瞻性统计量的人类研究。
- 采用随机效应模型计算前瞻性比值比(OR),分析时间为2021年5月至7月。
主要发现
- 所有线索与渴求指标与药物使用/复吸存在显著前瞻性关联(OR 2.05;95%CI 1.94-2.15),线索与渴求指标每增加1单位,未来药物使用或复吸的 odds 增加超过一倍。
- Trim-and-fill 分析调整后效应量为 OR 1.31(95%CI 1.25-1.38)。
- 调节分析显示线索诱导渴求、真实线索或图片、药物使用结局、同日时间间隔、使用生态瞬时评估的研究及男性参与者的关联较强。
临床怎么用
- 临床结果支持在治疗各阶段纳入渴求评估,早至初级保健。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Craving, which is a strong desire for drugs, is a new DSM-5 diagnostic criterion for substance use disorders (SUDs), which are the most prevalent, costly, and deadly forms of psychopathology. Despite decades of research, the roles of drug cues and craving in drug use and relapse remain controversial. OBJECTIVE: To assess whether 4 types of drug cue and craving indicators, including cue exposure, physiological cue reactivity, cue-induced craving, and self-reported craving (without cue exposure), are prospectively associated with drug use and relapse. DATA SOURCES: Google Scholar was searched for published studies from inception through December 31, 2018. In addition, backward and forward searches were performed on included articles to identify additional articles. STUDY SELECTION: Included studies reported a prospective statistic that linked cue and craving indicators at time 1 to drug use or relapse at time 2, in humans. DATA EXTRACTION AND SYNTHESIS: The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines were followed. Study characteristics and statistics were extracted and/or coded by 1 of the 2 authors and then checked by the other. Statistical analyses were performed from May to July 2021. MAIN OUTCOMES AND MEASURES: Random-effects models were used to calculate prospective odds ratios (ORs) representing the association between cue and craving indicators and subsequent drug use/relapse. RESULTS: A total of 18 205 records were identified, and 237 studies were included. Across 656 statistics, representing 51 788 human participants (21 216 with confirmed SUDs), a significant prospective association of all cue and craving indicators with drug use/relapse was found (OR, 2.05; 95% CI, 1.94-2.15), such that a 1-unit increase in cue and craving indicators was associated with more than double the odds of future drug use or relapse. A Rosenthal fail-safe analysis revealed that 180 092 null studies would need to be published to nullify this finding. Trim-and-fill analysis brought the adjusted effect size to an OR of 1.31 (95% CI, 1.25-1.38). Moderator analyses showed that some of the strongest associations were found for cue-induced craving, real cues or images, drug use outcome, same-day time lag, studies using ecological momentary assessment, and male participants. CONCLUSIONS AND RELEVANCE: Findings from this systematic review and meta-analysis suggest that drug cue and craving indicators play significant roles in drug use and relapse outcomes and are an important mechanism underlying SUDs. Clinically, these results support incorporating craving assessment across stages of treatment, as early as primary care.
引用
- Vafaie N, Kober H. Association of Drug Cues and Craving With Drug Use and Relapse: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022. PMID: 35648415. doi:10.1001/jamapsychiatry.2022.1240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。